- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01985568
Optimal Timing of Exercise Initiation Within a Lifestyle Weight Loss Program
September 27, 2023 updated by: University of Colorado, Denver
The primary aim of this study is to evaluate the extent to which an exercise intervention timed after diet-induced weight loss (rather than initiated at the same time) improves exercise adherence and long-term weight loss.
An 18 month randomized trial will be used to compare two behavioral weight loss programs; standard behavioral therapy (Standard BT) and sequential behavioral therapy (Sequential BT).
The Standard BT group will receive a traditional behavioral weight loss program where diet and exercise changes are initiated at the same time.
The Sequential BT group will receive a program that focuses solely on dietary changes in the initial 6 months, and then incorporates exercise in the ensuing 6 months.
Both groups will be followed for 18 months to assess long-term weight loss.
The hypothesis is that delivery of diet and exercise interventions in sequence will result in improved adherence to exercise and weight loss at 18 months when compared to a traditional program in which identical diet and exercise interventions are initiated at the same time.
This study could identify a strategy that could aid in the development of more effective obesity treatment programs and help more people achieve and sustain a weight loss.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
170
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado, Anschutz Health and Wellness Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age 18-55
- Body Mass Index 27-42 kilograms/meters squared
- Sedentary: defined as regular exercise of less than 100 minutes per week at moderate intensity or greater during the previous 6 months
- No self-report of acute or chronic disease (heart disease, diabetes, gastrointestinal disorders and orthopedic problems in particular)
- No plans to relocate or for extended travel (more than 1 week) within the next 18 months
- No current tobacco use
- Capable and willing to give informed consent, understand exclusion criteria, and accept the randomized group assignment
- Live or work within 20 minutes of the University of Colorado Anschutz Health and Wellness Center to ensure reasonable ability to comply with requirement to attend group weight loss sessions and supervised exercise sessions. Exceptions can be made at the discretion of the Study Principal Investigator (PI) on a case by case basis for highly motivated subjects.
For Females
- Not currently pregnant or lactating
- Not pregnant within the past 6 months
- Not planning to become pregnant in the next 18 months
- Sexually active women of childbearing potential may be enrolled if they have had a tubal ligation or use a reliable means of contraception.
Exclusion Criteria:
- Presence or history of health problems which would affect appetite, food intake, energy metabolism, or ability to optimally participate in the exercise component including: diabetes, cardiovascular disease, peripheral vascular disease, cerebrovascular disease, uncontrolled hypertension, uncontrolled hyper or hypothyroidism, cancer (within the last 5 years, except skin cancer), human immunodeficiency virus (HIV) infection, significant gastrointestinal, pulmonary, renal, musculoskeletal, neurologic, or hematologic disease
- Symptoms suggestive of cardiovascular disease: chest pain, shortness of breath at rest or with mild exertion, syncope
- Abnormal resting electrocardiogram (ECG): serious arrhythmias, including multifocal Premature Ventricular Contractions (PVCs), frequent PVC's (defined as 10 or more per minute), ventricular tachycardia (defined as runs of 3 or more successive PVC's), or sustained atrial tachyarrhythmia; 2nd or 3rd degree A-V block, corrected QT interval > 480 millisecond or other significant conduction defects
- Triglycerides > 400 milligram/deciliter (md/dL) or Low-Density Lipoprotein (LDL) cholesterol > 190 mg/dL
- Use of prescription or over-the-counter medications known to affect appetite, weight, heart rate response to exercise, or energy metabolism
- Use of systemic steroids (other than Oral Contraceptive Pills)
- Use of obesity pharmacotherapeutic agents within the last 6 months
- History of surgical procedure for weight loss
- History of major surgery within the past 3 months
- Current alcohol or substance abuse
- History of clinically diagnosed eating disorders including anorexia nervosa or bulimia
- Current severe depression or history of severe depression within the previous year
- History of other significant psychiatric illness (e.g. psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to dietary or exercise interventions
- Currently participating in or planning to participate in any formal weight loss or physical activity programs or clinical trials
- Weight loss or gain of > 5% in past 6 months for any reason except post-partum weight loss
- Participation in a weight loss program using the Colorado Weigh curriculum within the past 3 years (exceptions can be made at the discretion of the study PI on a case-by-case basis).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard Behavioral Therapy (Standard BT)
Standard BT: This group will follow a traditional model of initiating exercise concurrently with a dietary intervention for weight loss within an 18 month behavioral weight loss program.
|
Both study arms (Standard BT and Sequential BT) will receive an identical 6 month group-based weight loss program, followed by an identical 6 month group-based weight maintenance program, followed by an identical 6 months of weight maintenance phone support.
Both groups will also receive an identical 6 month exercise intervention.
Groups will differ only in the timing of exercise initiation.
Standard BT will begin exercise immediately upon starting the 6 month dietary weight loss intervention.
They will receive a progressive exercise program and exercise behavior support during months 0-6.
|
|
Experimental: Sequential Behavioral Therapy (Sequential BT)
Sequential BT: This group will receive diet and exercise interventions delivered sequentially within an 18 month behavioral weight loss program.
|
Both study arms (Standard BT and Sequential BT) will receive an identical 6 month group-based weight loss program, followed by an identical 6 month group-based weight maintenance program, followed by an identical 6 months of weight maintenance phone support.
Both groups will also receive an identical 6 month exercise intervention.
Groups will differ only in the timing of exercise initiation.
Sequential BT will be asked not to begin exercise during months 0-6.
They will receive a progressive exercise program and exercise behavior support during months 7-12.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body Weight
Time Frame: Baseline, 3, 6, 9, 12, 15, and 18 months.
|
Body weight will be assessed.
|
Baseline, 3, 6, 9, 12, 15, and 18 months.
|
|
Change in Body Composition
Time Frame: Baseline, 6, 12, and 18 months.
|
Body composition will be assessed.
|
Baseline, 6, 12, and 18 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objectively Measured Change in Physical Activity
Time Frame: Baseline, 6, 12, and 18 months.
|
Physical activity will be measured with activity monitors.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Maximal Aerobic Capacity
Time Frame: Baseline, 6, 12, and 18 months.
|
Maximal aerobic capacity will be measured.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Diet Composition
Time Frame: Baseline, 6, 12, and 18 months.
|
Dietary energy intake (calories/day) and fat intake (grams/day) will be measured.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Engagement in Weight Control Eating Behaviors
Time Frame: Baseline, 6, 12, and 18 months.
|
Engagement in weight control eating behaviors will be measured with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Dietary Weight Loss Program Attendance and Adherence
Time Frame: 18 months
|
Dietary weight loss program attendance and adherence will be assessed throughout the 18 month program.
|
18 months
|
|
Change in Exercise Program Attendance and Adherence
Time Frame: 18 months
|
Exercise program attendance and adherence will be assessed throughout the 18 month program.
|
18 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Number of Exercise Related Injuries and Adverse Events
Time Frame: 18 months
|
Exercise related injuries and adverse events will be assessed throughout the 18 month program.
|
18 months
|
|
Change in Mood
Time Frame: Baseline, 6, 12, and 18 months.
|
Mood will be assessed with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Exercise Self-Efficacy
Time Frame: Baseline, 6, 12, and 18 months.
|
Exercise self-efficacy will be assessed with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Diet Self-Efficacy
Time Frame: Baseline, 6, 12, and 18 months.
|
Diet self-efficacy will be assessed with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Beliefs About Exercise Benefits and Barriers
Time Frame: Baseline, 6, 12, and 18 months.
|
Beliefs about exercise benefits and barriers will be assessed with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Motivation to Engage in a Weight Loss Treatment Program
Time Frame: Baseline, 6, 12, and 18 months.
|
Motivation for engaging in a weight-loss treatment program will be assessed with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Motivation to Engage in Exercise
Time Frame: Baseline, 6, 12, and 18 months.
|
Motivation to engage in exercise will be assessed with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Physical Activity Enjoyment
Time Frame: Baseline, 6, 12, and 18 months.
|
Physical activity enjoyment will be assessed with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Dietary Self-Control
Time Frame: Baseline, 6, 12, and 18 months.
|
Dietary self-control will be assessed with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Perceived Effort for Weight Control
Time Frame: Baseline, 6, 12, and 18 months.
|
Perceived effort for weight control will be measured with a questionnaire.
|
Baseline, 6, 12, and 18 months.
|
|
Change in Post intervention follow-up
Time Frame: 24 months
|
Weight, objectively measured physical activity, and outcome measures #6 and #10-18 will be assessed 6 months after completion of intervention.
|
24 months
|
|
Change in Genetic and Epigenetic markers
Time Frame: Baseline
|
Baseline genetic and epigenetic biomarkers will be analyzed to determine if they are associated with baseline measures and/or changes in post-intervention measure outcomes.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Victoria Catenacci, MD, University of Colorado Anschutz Health and Wellness Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Creasy SA, Ostendorf DM, Blankenship JM, Grau L, Arbet J, Bessesen DH, Melanson EL, Catenacci VA. Effect of sleep on weight loss and adherence to diet and physical activity recommendations during an 18-month behavioral weight loss intervention. Int J Obes (Lond). 2022 Aug;46(8):1510-1517. doi: 10.1038/s41366-022-01141-z. Epub 2022 May 16.
- Ostendorf DM, Schmiege SJ, Conroy DE, Phelan S, Bryan AD, Catenacci VA. Motivational profiles and change in physical activity during a weight loss intervention: a secondary data analysis. Int J Behav Nutr Phys Act. 2021 Dec 4;18(1):158. doi: 10.1186/s12966-021-01225-5.
- Catenacci VA, Ostendorf DM, Pan Z, Bing K, Wayland LT, Seyoum E, Stauffer BL, Phelan S, Creasy SA, Caldwell AE, Wyatt HR, Bessesen DH, Melanson EL. The Impact of Timing of Exercise Initiation on Weight Loss: An 18-Month Randomized Clinical Trial. Obesity (Silver Spring). 2019 Nov;27(11):1828-1838. doi: 10.1002/oby.22624. Epub 2019 Sep 29.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
September 1, 2018
Study Completion (Actual)
September 1, 2018
Study Registration Dates
First Submitted
October 24, 2013
First Submitted That Met QC Criteria
November 8, 2013
First Posted (Estimated)
November 15, 2013
Study Record Updates
Last Update Posted (Actual)
September 28, 2023
Last Update Submitted That Met QC Criteria
September 27, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-1550
- R01DK097266 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Standard BT
-
Mackay Medical CollegeRecruiting
-
Better TherapeuticsCompletedType 2 DiabetesUnited States
-
NImmune BiopharmaWithdrawnEosinophilic Esophagitis
-
JSR Medical Co., Ltd.RecruitingColorectal Cancer | Colorectal Surgery | Ileostomy - Stoma | Rectal/Anal | Anastomotic LeakageUnited States
-
Biora Therapeutics, Inc.Completed
-
NImmune BiopharmaCompletedUlcerative ColitisUnited States, Bosnia and Herzegovina, Croatia, Poland, Ukraine
-
University of British ColumbiaUnknownBrain Injuries, Traumatic | Cerebrovascular Trauma | Acute Brain InjuriesCanada
-
Fujian Cancer HospitalCompletedNasopharyngeal Cancer RecurrentChina
-
University Children's Hospital, ZurichCompletedTime Until Identification of Defined ParameterSwitzerland
-
Ankara Training and Research HospitalCompleted